Seed VC · London, United Kingdom
4Bio Capital is a London-based venture capital firm specializing in investments in advanced therapies, including gene and cell therapies, RNA-based treatments, and targeted oncology. Established in 2018, the firm focuses on supporting early-stage and growth-stage biotechnology companies with transformative potential in the life sciences sector. 4Bio Capital is recognized for its scientific expertise and active involvement in portfolio companies, aiming to accelerate the development of innovative medical solutions. The firm has built a strong reputation within the biotech investment community and maintains key operations in both Europe and the United States.
Business models
biotech_therapeutics, deeptech_ip
Customer segments
Researchers, Hospital systems, Patients
Geography
UK, Europe, US, APAC
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
4Bio Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks 4Bio Capital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Seed VC
4BIO Capital
advanced therapies, gene therapy, life sciences
Family Office
Aeternum Management AS
life sciences, healthcare, medical devices
Seed VC
Apeiron Investment Group
longevity, healthcare, life sciences
Seed VC
Armira
mid-market manufacturing, tech, health
Family Office
EQT Foundation
deeptech, life sciences, climate tech
Family Office
Feldberg Capital
real estate, residential, industrial & logistics
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. 4Bio Capital is one of them, and we'll tell you exactly where they sit in your top 100.